1. Repository of OAI
Ελληνικά   English  

Browsing by Author Elisaf, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 38 to 57 of 87 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Tambaki, A. P.; Abatzis, M.; Biris, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Soteriadou, K.; Goudevenos, J.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Effects of anithypertensive and hypolipidemic drugs on plasma and lipoprotein-associated PAF-acetylhydrolaseTsimihodimos, V.; Tambaki, A.; Rizos, E.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activityTambaki, A. P.; Rizos, E.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
The Effects of Ezetimibe and Orlistat, Alone or in Combination, on High Density Lipoprotein (Hdl) Subclasses and Hdl-Associated Enzyme Activities in Overweight and Obese Patients with HyperlipidaemiaNakou, E.; Filippatos, T.; Kiortsis, D.; Derdemezis, C.; Georgoula, M.; Petraki, M.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot StudyFlorentin, M.; Liberopoulos, E. N.; Tellis, C. C.; Derdemezis, C. S.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levelsBairaktari, E.; Hatzidimou, K.; Tzallas, C.; Vini, M.; Katsaraki, A.; Tselepis, A.; Elisaf, M.; Tsolas, O.24-Nov-2015-
European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesMikhailidis, D. P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V. G.; de Graaf, J.; Marz, W.; Parhofer, K. G.; Rini, G. B.; Spinas, G. A.; Tomkin, G. H.; Tselepis, A. D.; Wierzbicki, A. S.; Winkler, K.; Florentin, M.; Liberopoulos, E.24-Nov-2015-
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patientsBairaktari, E.; Elisaf, M.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
Evaluation of the ability of simple lipid measures to predict the presence of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kalogirou, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteinsTsimihodimos, V.; Kakafika, A.; Tambaki, A. P.; Bairaktari, E.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic populationMiltiadous, G.; Hatzivassiliou, M.; Liberopoulos, E.; Bairaktari, E.; Tselepis, A.; Cariolou, M.; Elisaf, M.24-Nov-2015-
Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levelsSkrapari, I.; Perrea, D.; Ioannidis, I.; Karabina, S. A. P.; Elisaf, M.; Tselepis, A. D.; Karagiannacos, P.; Katsilambros, N.24-Nov-2015-
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysisLiberopoulos, E.; Papavasiliou, E.; Tzallas, C.; Katopodis, K.; Gouva, C.; Christidis, D.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A. P.; Elisaf, M.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemiaElisaf, M.; Karabina, S. A. P.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
The influence of serum apolipoprotein e concentration and polymorphism on serum lipid parameters in hemodialysis patientsLiberopoulos, E.; Miltiadous, G.; Cariolou, M.; Katopodis, K.; Tselepis, A.; Siamopoulos, K. C.; Elisaf, M.24-Nov-2015-
Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative studyTselepis, A. D.; Rodi, F. I.; Mitsios, J. V.; Stathopoulos, P.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Michalis, L. K.; Goudevenos, J. A.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Sideris, D. A.24-Nov-2015-
Showing results 38 to 57 of 87 < previous   next >